BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs2476601, PDX1, Coagulation, Lung cancer, Adipose tissue, Autoimmunity, Ciprofibrate)
Bookmark Forward

QuickView for R-SMAD binding (biogroup)


Body Atlas

Most Correlated Tissues

  1. Aorta
  2. Urethra
  3. Salivary gland
  4. Joint synovium
  5. Synovial membrane
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Pyloric ulcer
  2. Placental insufficiency
  3. Peritoneal foreign body
  4. Pneumonia
  5. Injury of integument
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. sitagliptin
  2. A 443654
  3. flavopiridol
  4. GSK-1059615
  5. CGP 60474
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. P4HTM
  2. PCDH11X
  3. PPP2R2C
  4. IRF7
  5. SINHCAF
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. Pancreatic microRNA expression profiles throughout differentiation
  2. Apelin and APJ knockdown in pulmonary artery endothelial cells
  3. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
  4. L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
  5. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg syndrome.
  2. Structural basis for the cooperative DNA recognition by Smad4 MH1 dimers.
  3. TMEPAI, a transmembrane TGF-beta-inducible protein, sequesters Smad proteins from active participati…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Phase I/II for Safety and Efficacy of Nilotinib in a Population Steroid-refractory/or Steroid-depend…
  2. Clinical, Functional, Immunological and Genetic Factors on the Severity of the Course of Coronavirus…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.